EpCAM driven classification managed to reach 91% AUC with 89% balanced accuracy on the CTC test set and only 53.7% AUC on primary tumor set, as opposed to 95% balanced accuracy on the CTC test set and 99% on the primary tumor set. This evidence concerns the gene EPCAM and neoplasm.